Niacinamide

nicotinamide phosphoribosyltransferase ; Homo sapiens







68 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35219878 NAMPT: A critical driver and therapeutic target for cancer. 2022 Apr 2
2 35251333 Sirtuin 1 participates in intervertebral disc degeneration via the nicotinamide phosphoribosyl transferase/nicotinamide adenine dinucleotide/sirtuin 1 pathway responsible for regulating autophagy of nucleus pulposus cells. 2022 Apr 1
3 35408818 NAD+ Anabolism Disturbance Causes Glomerular Mesangial Cell Injury in Diabetic Nephropathy. 2022 Mar 22 1
4 33446046 Accelerated cardiovascular risk after viral clearance in hepatitis C patients with the NAMPT-rs61330082 TT genotype: An 8-year prospective cohort study. 2021 Dec 1
5 34201564 eNAMPT Is Localised to Areas of Cartilage Damage in Patients with Hip Osteoarthritis and Promotes Cartilage Catabolism and Inflammation. 2021 Jun 23 1
6 34229568 Structure-based virtual screening, molecular dynamics simulation and in vitro evaluation to identify inhibitors against NAMPT. 2021 Jul 6 2
7 34430962 The Role of Visfatin (Adipocytokine) Biomarker in Oral Health and Diseases among Nonobese Indian Population: A Proteomic Assay. 2021 Sep 1
8 31818629 Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening. 2020 Jan 1 2
9 31898286 α-Mangostin reduced the viability of A594 cells in vitro by provoking ROS production through downregulation of NAMPT/NAD. 2020 Jan 1
10 31919382 The effect of NAMPT deletion in projection neurons on the function and structure of neuromuscular junction (NMJ) in mice. 2020 Jan 9 1
11 31988240 A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus. 2020 Mar 13 2
12 32005247 Targeting the NAD+ salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/β-catenin signaling via increasing Axin level. 2020 Jan 31 2
13 32252104 Serum Visfatin does not seem to be a Useful Marker to Guide Glucocorticoid Substitution in Adrenal Insufficiency. 2020 May 1
14 32266141 NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation. 2020 1
15 32428995 Impaired nicotinamide adenine dinucleotide (NAD+ ) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment. 2020 Nov 2
16 32822582 Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells. 2020 Nov 5 1
17 32878777 Effect of Phosphoribosyltransferase Down-regulation on Malignant Glioma Cell Characteristics. 2020 Sep 2
18 30514106 SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells. 2019 Mar 1
19 30875389 Quantitative analysis of the effects of nicotinamide phosphoribosyltransferase induction on the rates of NAD+ synthesis and breakdown in mammalian cells using stable isotope-labeling combined with mass spectrometry. 2019 2
20 31338216 Targeting NAMPT as a therapeutic strategy against stroke. 2019 Jul 1
21 31614144 High expression of NAMPT in adult T-cell leukemia/lymphoma and anti-tumor activity of a NAMPT inhibitor. 2019 Dec 15 1
22 31803365 Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent. 2019 Nov 19 1
23 31888244 Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin. 2019 Dec 16 1
24 29207896 Rho GTPase effectors and NAD metabolism in cancer immune suppression. 2018 Jan 2
25 29478906 Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites. 2018 Apr 19 2
26 29541451 Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA. 2018 1
27 29653431 Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway. 2018 Jun 2
28 28035412 Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation in vitro. 2017 Feb 1
29 28468779 Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors. 2017 Jul 2
30 28756225 Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD+ biosynthesis pathway and NAMPT mutation. 2017 Sep 23 2
31 28819322 NAMPT enzyme activity regulates catabolic gene expression in gingival fibroblasts during periodontitis. 2017 Aug 18 2
32 29156703 Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer. 2017 Oct 17 2
33 27018006 Targeting Nicotinamide Phosphoribosyltransferase as a Potential Therapeutic Strategy to Restore Adult Neurogenesis. 2016 Jun 3
34 27608947 NAMPT inhibition synergizes with NQO1-targeting agents in inducing apoptotic cell death in non-small cell lung cancer cells. 2016 Aug 2
35 27711204 Metabolic Response to NAD Depletion across Cell Lines Is Highly Variable. 2016 2
36 25656579 FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells. 2015 Mar 6 2
37 25894564 Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid. 2015 Mar 2
38 26024774 Apoptosis induced by NAD depletion is inhibited by KN-93 in a CaMKII-independent manner. 2015 Jul 1 1
39 26330291 A Nampt inhibitor FK866 mimics vitamin B3 deficiency by causing senescence of human fibroblastic Hs68 cells via attenuation of NAD(+)-SIRT1 signaling. 2015 Dec 1
40 26542945 EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition. 2015 Nov 5 2
41 24389478 Discovery of a novel nicotinamide phosphoribosyl transferase (NAMPT) inhibitor via in silico screening. 2014 2
42 23435312 NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity. 2013 Jun 5
43 23880765 CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. 2013 Sep 6 1
44 24403854 Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models. 2013 Dec 1
45 22044451 Pre-B-cell colony-enhancing factor exerts a neuronal protection through its enzymatic activity and the reduction of mitochondrial dysfunction in in vitro ischemic models. 2012 Jan 2
46 22430142 NAMPT pathway is involved in the FOXO3a-mediated regulation of GADD45A expression. 2012 Apr 20 2
47 20956937 NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. 2011 Feb 24 1
48 21517777 NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism. 2011 1
49 21826208 Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma. 2011 1
50 21884623 Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/Visfatin/NMPRTase for glioma therapy. 2011 Jan 20 1